poisar

Stocks · News reference

Freenome shares are trading higher after the company announced the launch of SimpleScreen Lung and a first-of-its-kind offering that enables eligible patients to be screened for both lung and colorectal cancer through a single blood draw.

BenzingaBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Freenome, Inc. (FRNM)

    Filed: 2026-10-20 AccNo: 0001140361-26-040186 Size: 205 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits